Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexibuprofen oral suspension versus ibuprofen oral suspension for fever in children with acute lower respiratory tract infection
ChiCTR2500101700Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexibuprofen and ibuprofen in acute lower respiratory tract infection (LRTI) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Change in body temperature at 4 hours after administration. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
dexibuprofenibuprofen
03
Conditions
acute lower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on ChiCTR2500101700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101700.